* We recommend a score >= 0.08 for meaningful Gene-Disease associations
| GeneID | Gene_Symbol | DisGeNet_diseaseID | Disease_name | DisGeNet_sourceDB | |
| 6502 | SKP2 | C2239176 | Liver carcinoma | 0.207403267796436 | BEFREE;CTD_human;LHGDN |
| 6502 | SKP2 | C0919267 | ovarian neoplasm | 0.203007639249027 | BEFREE;CTD_human;LHGDN |
| 6502 | SKP2 | C0079744 | Diffuse Large B-Cell Lymphoma | 0.200549453568426 | BEFREE;CTD_human |
| 6502 | SKP2 | C0025149 | Medulloblastoma | 0.2 | CTD_human |
| 6502 | SKP2 | C1458155 | Mammary Neoplasms | 0.0196798408221225 | BEFREE;LHGDN |
| 6502 | SKP2 | C0007137 | Squamous cell carcinoma | 0.0174963819257349 | BEFREE;LHGDN |
| 6502 | SKP2 | C0025202 | melanoma | 0.0123052837803205 | BEFREE;LHGDN |
| 6502 | SKP2 | C0027627 | Neoplasm Metastasis | 0.0120449123734247 | BEFREE;LHGDN |
| 6502 | SKP2 | C0024121 | Lung Neoplasms | 0.0112063766434681 | BEFREE;LHGDN |
| 6502 | SKP2 | C0006142 | Malignant neoplasm of breast | 0.0092096855939856 | BEFREE;GAD |
| 6502 | SKP2 | C0024299 | Lymphoma | 0.0065647320664799 | BEFREE;LHGDN |
| 6502 | SKP2 | C0596263 | Carcinogenesis | 0.0057692624684751 | BEFREE |
| 6502 | SKP2 | C0033578 | Prostatic Neoplasms | 0.0057405517138406 | BEFREE;LHGDN |
| 6502 | SKP2 | C0678222 | Breast Carcinoma | 0.0043956285474096 | BEFREE |
| 6502 | SKP2 | C0376358 | Malignant neoplasm of prostate | 0.0038461749789834 | BEFREE |
| 6502 | SKP2 | C0027819 | Neuroblastoma | 0.00383181960166615 | BEFREE;LHGDN |
| 6502 | SKP2 | C0600139 | Prostate carcinoma | 0.0035714481947703 | BEFREE |
| 6502 | SKP2 | C0019163 | Hepatitis B | 0.00355709281745305 | BEFREE;LHGDN |
| 6502 | SKP2 | C0001418 | Adenocarcinoma | 0.00300763924902685 | BEFREE;LHGDN |
| 6502 | SKP2 | C0007134 | Renal Cell Carcinoma | 0.00300763924902685 | BEFREE;LHGDN |
| 6502 | SKP2 | C0023418 | leukemia | 0.00300763924902685 | BEFREE;LHGDN |
| 6502 | SKP2 | C1140680 | Malignant neoplasm of ovary | 0.0029564820917142 | BEFREE;GAD |
| 6502 | SKP2 | C0009404 | Colorectal Neoplasms | 0.00273291246481375 | LHGDN |
| 6502 | SKP2 | C0010606 | Adenoid Cystic Carcinoma | 0.00273291246481375 | LHGDN |
| 6502 | SKP2 | C0014170 | Endometrial Neoplasms | 0.00273291246481375 | LHGDN |
| 6502 | SKP2 | C0023467 | Leukemia, Myelocytic, Acute | 0.00273291246481375 | LHGDN |
| 6502 | SKP2 | C0032019 | Pituitary Neoplasms | 0.00273291246481375 | LHGDN |
| 6502 | SKP2 | C0040136 | Thyroid Neoplasm | 0.00273291246481375 | LHGDN |
| 6502 | SKP2 | C0242379 | Malignant neoplasm of lung | 0.0019230874894917 | BEFREE |
| 6502 | SKP2 | C0699791 | Stomach Carcinoma | 0.0016483607052786 | BEFREE |
| 6502 | SKP2 | C0007131 | Non-Small Cell Lung Carcinoma | 0.0016483607052786 | BEFREE |
| 6502 | SKP2 | C0684249 | Carcinoma of lung | 0.0013736339210655 | BEFREE |
| 6502 | SKP2 | C1306460 | Primary malignant neoplasm of lung | 0.0013736339210655 | BEFREE |
| 6502 | SKP2 | C0686619 | Secondary malignant neoplasm of lymph node | 0.0010989071368524 | BEFREE |
| 6502 | SKP2 | C0700095 | Central neuroblastoma | 0.0010989071368524 | BEFREE |
| 6502 | SKP2 | C1335302 | Pancreatic Ductal Adenocarcinoma | 0.0010989071368524 | BEFREE |
| 6502 | SKP2 | C0178874 | Tumor Progression | 0.0010989071368524 | BEFREE |
| 6502 | SKP2 | C0279626 | Squamous cell carcinoma of esophagus | 0.0008241803526393 | BEFREE |
| 6502 | SKP2 | C0009402 | Colorectal Carcinoma | 0.0008241803526393 | BEFREE |
| 6502 | SKP2 | C0017636 | Glioblastoma | 0.0008241803526393 | BEFREE |
| 6502 | SKP2 | C0023903 | Liver neoplasms | 0.0008241803526393 | BEFREE |
| 6502 | SKP2 | C0024623 | Malignant neoplasm of stomach | 0.0008241803526393 | BEFREE |
| 6502 | SKP2 | C0235974 | Pancreatic carcinoma | 0.0005494535684262 | BEFREE |
| 6502 | SKP2 | C0238198 | Gastrointestinal Stromal Tumors | 0.0005494535684262 | BEFREE |
| 6502 | SKP2 | C0278883 | Metastatic melanoma | 0.0005494535684262 | BEFREE |
| 6502 | SKP2 | C0278996 | Cancer of Head and Neck | 0.0005494535684262 | BEFREE |
| 6502 | SKP2 | C0598766 | Leukemogenesis | 0.0005494535684262 | BEFREE |
| 6502 | SKP2 | C1512409 | Hepatocarcinogenesis | 0.0005494535684262 | BEFREE |
| 6502 | SKP2 | C1527249 | Colorectal Cancer | 0.0005494535684262 | BEFREE |
| 6502 | SKP2 | C2931822 | Nasopharyngeal carcinoma | 0.0005494535684262 | BEFREE |
| 6502 | SKP2 | C0014175 | Endometriosis | 0.0005494535684262 | BEFREE |
| 6502 | SKP2 | C0023473 | Myeloid Leukemia, Chronic | 0.0005494535684262 | BEFREE |
| 6502 | SKP2 | C0029925 | Ovarian Carcinoma | 0.0005494535684262 | BEFREE |
| 6502 | SKP2 | C0032002 | Pituitary Diseases | 0.0005494535684262 | BEFREE |
| 6502 | SKP2 | C0149925 | Small cell carcinoma of lung | 0.0005494535684262 | BEFREE |
| 6502 | SKP2 | C0220668 | Congenital contractural arachnodactyly | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0233629 | Thinking and speaking disturbances | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0235782 | Gallbladder Carcinoma | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0282160 | Aplasia Cutis Congenita | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0334317 | Cystadenofibroma | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0334634 | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0346647 | Malignant neoplasm of pancreas | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0521720 | Corneal fibrosis | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0546837 | Malignant neoplasm of esophagus | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0699790 | Colon Carcinoma | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0699885 | Carcinoma of bladder | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0750952 | Biliary Tract Cancer | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0878500 | Intraepithelial Neoplasia | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0948216 | ovarian adenocarcinoma | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C1134719 | Invasive Ductal Breast Carcinoma | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C1168327 | High-Grade Prostatic Intraepithelial Neoplasia | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C1336745 | Thymic Lymphoma | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C1621958 | Glioblastoma Multiforme | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C1961099 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C2745900 | Promyelocytic leukemia | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C3539878 | Triple Negative Breast Neoplasms | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C3714524 | Fibromyxosarcoma | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C3805278 | Extrahepatic Cholangiocarcinoma | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C3854222 | Human immunodeficiency virus (HIV) II infection category B1 | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0001430 | Adenoma | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0002793 | Anaplasia | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0003504 | Aortic Valve Insufficiency | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0003850 | Arteriosclerosis | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0004114 | Astrocytoma | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0004153 | Atherosclerosis | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0005684 | Malignant neoplasm of urinary bladder | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0005695 | Bladder Neoplasm | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0006413 | Burkitt Lymphoma | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0007102 | Malignant tumor of colon | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0014859 | Esophageal Neoplasms | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0017638 | Glioma | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0019693 | HIV Infections | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0022658 | Kidney Diseases | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0023434 | Chronic Lymphocytic Leukemia | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0023470 | Myeloid Leukemia | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0023487 | Acute Promyelocytic Leukemia | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0024301 | Lymphoma, Follicular | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0025322 | Premature Menopause | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0026764 | Multiple Myeloma | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0035335 | Retinoblastoma | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0036220 | Kaposi Sarcoma | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0041956 | Ureteral obstruction | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0085215 | Ovarian Failure, Premature | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0085390 | Li-Fraumeni Syndrome | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0085695 | Chronic gastritis | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0152018 | Esophageal carcinoma | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0153381 | Malignant neoplasm of mouth | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0153567 | Uterine Cancer | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0153676 | Secondary malignant neoplasm of lung | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0175754 | Agenesis of corpus callosum | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0206698 | Cholangiocarcinoma | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0206769 | Nevi and Melanomas | 0.0002747267842131 | BEFREE |
| 6502 | SKP2 | C0220641 | Lip and Oral Cavity Carcinoma | 0.0002747267842131 | BEFREE |